atrial fibrillation, persistent, StudyID: Flec-SL 2012
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2012 Jul 21;380(9838):238-46 Randomized Controlled Trial
IN atrial fibrillation, persistent, StudyID: Flec-SL 2012 The Use of
flecainide
As Treatment, Chronic
Is better Than
no treatment
To reduce recurrences of AF at 4 weeks: 52% flecainide VS 70% no Tt. It seems the control group was not continued afterwards